ClosedHealth & Human Services
Maternal Health Research Collaborative for Minority-Serving Institutions (MH-RC-MSI) Coordinating Center (CC)
Health Resources and Services AdministrationHRSA-23-113
Description
This notice announces the opportunity to apply for funding under HRSA-23-112: Maternal Health Research Collaborative for Minority-Serving Institutions (MH-RC-MSI) Research Centers (RCs) and HRSA-23-113: MH-RC-MSI Coordinating Center (CC).The purpose of the Maternal Health Research Collaborative for Minority-Serving Institutions (MSIs)3 [hereafter referred to as the Collaborative] is to establish a multi-institutional research network that is comprised of and supports minority-serving institutions (MSIs) to build their capacity to conduct research addressing disparities in maternal mortality, severe maternal morbidity, and maternal health outcomes and to find community-based solutions to address these disparities and advance health equity. The Collaborative consists of two funding announcements. • HRSA-23-112: MH-RC-MSI (RCs) will build the capacity of MSIs to conduct maternal health disparity research. • HRSA-23-113: MH-RC-MSI (CC) will provide technical assistance and other support to the RCs to help them build their institution’s research capacity in maternal health disparity research. HRSA-23-113: MH-RC-MSI (CC) The goal of HRSA-23-113 is to build the research capacity of the RCs or their partner MSI and other MSIs to conduct maternal health disparity research. The award recipient will also provide support in meeting the RCs’ project objectives. The CC will collect data to measure and evaluate the Collaborative’s impact and effectiveness, and enhance the RCs’ productivity, efficiency, and public health impact. The following objectives should be accomplished by the end of the period of performance: 1. Develop training materials, tools, and toolkits to enhance the capacity of the RCs to conduct maternal health disparity research. 2. Convene and support a learning community of MSIs to conduct maternal health disparity research, promote scientific collaborations, and build synergy among MSIs. 3. Establish a data infrastructure to collect and share data across the RCs. 4. Increase the number of diverse, early-stage investigators from underserved communities trained in maternal health disparity research. 5. Disseminate research findings from RCs to communities, policymakers, researchers, and other stakeholders. 6. Develop strategies and tools to accelerate and translate the research into practice with a focus on addressing health disparities and equity in communities. 7. Evaluate the overall impact of the Collaborative on achieving its goal to build MSI capacity to reduce maternal health disparities. For more details, see Program Requirements and Expectations.
Award Ceiling
$2.4M
Total Funding
$2.2M
CFDA Number
93.110
Funding Instrument
Cooperative Agreement
Funding Level
Federal
Jurisdiction
US
Cost Sharing
No
Open Date
April 13, 2023
Close Date
June 12, 2023
Posted Date
April 13, 2023
Eligible Applicant Types
City or township governmentsSpecial district governmentsIndependent school districtsOthers (see text field entitled "Additional Information on Eligibility" for clarification)State governmentsPublic and State controlled institutions of higher educationCounty governmentsNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationPrivate institutions of higher education
Tags
HHS-HRSACFDA:93.110Cooperative AgreementHealth
Related Health & Human Services Grants
NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed)
National Institutes of Health
0d left
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
National Institutes of Health
0d left
HIV Prevention and Alcohol (R01 Clinical Trials Optional)
National Institutes of Health
0d left
Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trial Not Allowed)
National Institutes of Health
0d left